Home > Insider Trading > Filing (0001213900-20-027008)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
352998	Teligent Inc.	TLGT	Pharmaceutical Preparations (2834)	010355758

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
904778	A Don Sanders	600 Travis, Suite 5900 Houston TX 77002	No	No	Yes	No
1006309	V Donald Weir	600 Travis, Suite 5900 Houston TX 77002	No	No	Yes	No
1184312	C James Gale	152 West 57Th Street 59Th Floor New York NY 10019	Yes	No	Yes	No
1214494	T Ben Morris	600 Travis, Suite 5900 Houston TX 77002	No	No	Yes	No
1269415	Life Sciences Opportunities Fund Ii Lp	152 West 57Th Street 59Th Floor New York NY 10019	No	No	Yes	No
1269417	Life Sciences Opportunities Fund Instittutional Ii Lp	152 West 57Th Street 59Th Floor New York NY 10019	Yes	No	Yes	No
1280952	Signet Healthcare Partners, Llc	152 West 57Th Street 59Th Floor New York NY 10019	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2020-08-19	74,020	$2.26	761,680	No	4	S	Direct
Common Stock	Disposition	2020-08-19	13,251	$2.25	136,237	No	4	S	Direct
Common Stock	Disposition	2020-08-21	102,962	$1.66	658,718	No	4	S	Direct
Common Stock	Disposition	2020-08-21	18,432	$1.66	117,805	No	4	S	Direct
Common Stock	Disposition	2020-08-25	84,816	$1.13	573,902	No	4	S	Direct
Common Stock	Disposition	2020-08-25	15,184	$1.13	102,621	No	4	S	Direct
Common Stock	Disposition	2020-08-26	475,512	$1.24	98,390	No	4	S	Direct
Common Stock	Disposition	2020-08-26	85,106	$1.25	17,515	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

These securities are owned directly by Life Sciences Opportunities Fund (Institutional) II, L.P. and indirectly by the Signet Healthcare Partners, LLC ("General Partner"), the general partner of Life Sciences Opportunities Fund II, L.P., James C. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW Investments I, LLC ("SMW") and Don A. Sanders, Ben T. Morris, and Donald V. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any.
These securities are owned directly by Life Sciences Opportunities Fund II, L.P. and indirectly by the General Partner, Mr. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW, and Mr. Sanders, Mr. Morris, and Mr. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any.